pyrimethamine has been researched along with Focal Neurologic Deficits in 8 studies
Maloprim: contains above 2 cpds
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DAILLY, R | 1 |
Townsend, JJ | 1 |
Wolinsky, JS | 1 |
Baringer, JR | 1 |
Johnson, PC | 1 |
Diop Mar, I | 1 |
Sow, A | 1 |
Payet, M | 1 |
Coulaud, JP | 1 |
Pasticier, A | 1 |
Saimot, G | 1 |
Zinchenko, AP | 1 |
Merkulova, GP | 1 |
Brooks, MH | 1 |
Barry, KG | 1 |
Wick, H | 1 |
8 other studies available for pyrimethamine and Focal Neurologic Deficits
Article | Year |
---|---|
[ACQUIRED TOXOPLASMOSIS].
Topics: Antifungal Agents; Diagnosis; Diagnosis, Differential; Exanthema; Humans; Lymphadenitis; Meningitis; | 1964 |
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease.
Topics: Adult; Bronchopneumonia; Clinical Laboratory Techniques; Female; Fluorescent Antibody Technique; Hod | 1975 |
[Treatment of cerebral malaria with a fansidar-hydergine combination].
Topics: Adolescent; Adult; Antimalarials; Brain Diseases; Child; Child, Preschool; Coma; Drug Combinations; | 1973 |
[Tropical and parasitic diseases].
Topics: Acute Kidney Injury; Amebiasis; Antimalarials; Cholera; Drug Resistance, Microbial; Encephalitis; Gl | 1974 |
[Clinical aspects, course and therapy of disseminated encephalomyelitis in chronic acquired toxoplasmosis].
Topics: Adolescent; Adult; Antiprotozoal Agents; Chronic Disease; Drug Therapy, Combination; Encephalomyelit | 1974 |
Fatal transfusion malaria.
Topics: Blood Volume; Chloroquine; Chorea; Dehydration; Dexamethasone; Humans; Malaria; Male; Middle Aged; N | 1969 |
[Toxoplasmosis].
Topics: Adult; Brain; Calcinosis; Chorioretinitis; Demeclocycline; Encephalomyelitis; Female; Humans; Hydroc | 1969 |
[Polycythemia vera with neurologic complications in a 12-year-old child].
Topics: Anticoagulants; Child; Diagnosis, Differential; Female; Humans; Myeloproliferative Disorders; Neurol | 1969 |